產品詳情
簡單介紹：
Anti-FIP1L1抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-FIP1L1抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-FIP1L1
Cat. Number:
Anti-FIP1L1抗體KL-13173R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The Component of the Cleavage and Polyadenylation Specificity Factor (CPSF) complex plays an important role in the 3'-end formation of pre-mRNA. This complex recognizes the AAUAAA signal sequence and interacts with poly(A) polymerase to process and add to the poly(A) tail. FIP1L1 (FIP1-like 1), also known as Pre-mRNA 3'-end-processing factor FIP1, FIP1 (Factor interacting with PAP) and RHE (Rearranged in hypereosinophilia),Anti-FIP1L1抗體 is a 594 amino acid nuclear protein that is a component of the CPSF complex. Within the complex, FIP1L1 contributes to the poly(A) recognition and stimulates poly(A) addition. Fusion of the genes encoding FIP1L1 and PDGFRA due to an interstitial deletion on chromosome 4q12 is the cause of hypereosinophilia syndrome, a rare blood disorder characterized by continuous overproduction of eosinophils in the bone marrow that leads to tissue infiltration and organ damage. There are three isoforms of FIP1L1 that are produced as a result of alternative splicing events.
Also known as:
DKFZp586K0717; Factor interacting with PAP;Anti-FIP1L1抗體 FIP1; FIP1 like 1 (S cerevisiae); FIP1 like 1; FLJ33619; hFip 1; hFip1; Pre mRNA 3 end processing factor FIP1; Rearranged in hypereosinophilia; RHE; FIP1_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human FIP1L1.
●
Predicted Molecular Weight:Anti-FIP1L1抗體 66kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-FIP1L1抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-FIP1L1抗體
Optimal working dilutions must be determined by the end user.
kl021Ra01 睫狀神經營養因子(CNTF)多克隆抗體 Polyclonal Antibody to Ciliary Neurotrophic Factor (CNTF)
kl021Rb51 睫狀神經營養因子(CNTF)多克隆抗體 Polyclonal Antibody to Ciliary Neurotrophic Factor (CNTF)
kl022Bo01 血管內皮細胞蛋白C受體(PROCR)多克隆抗體 Polyclonal Antibody to Protein C Receptor, Endothelial (PROCR)
kl022Ga01 血管內皮細胞蛋白C受體(PROCR)多克隆抗體 Polyclonal Antibody to Protein C Receptor, Endothelial (PROCR)
kl022Hu01 血管內皮細胞蛋白C受體(PROCR)多克隆抗體 Polyclonal Antibody to Protein C Receptor, Endothelial (PROCR)
kl022Mu01 血管內皮細胞蛋白C受體(PROCR)多克隆抗體 Polyclonal Antibody to Protein C Receptor, Endothelial (PROCR)
kl022Po01 血管內皮細胞蛋白C受體(PROCR)多克隆抗體 Polyclonal Antibody to Protein C Receptor, Endothelial (PROCR)
kl022Ra01 血管內皮細胞蛋白C受體(PROCR)多克隆抗體 Polyclonal Antibody to Protein C Receptor, Endothelial (PROCR)
kl024Bo01 ***腺來源血管內皮生長因子(EG-VEGF)多克隆抗體 Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Hu01 ***腺來源血管內皮生長因子(EG-VEGF)多克隆抗體 Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Mu01 ***腺來源血管內皮生長因子(EG-VEGF)多克隆抗體 Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Ra01 ***腺來源血管內皮生長因子(EG-VEGF)多克隆抗體 Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl025Bo01 嗜酸粒細胞趨化因子(ECF)多克隆抗體 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Eq01 嗜酸粒細胞趨化因子(ECF)多克隆抗體 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Gu01 嗜酸粒細胞趨化因子(ECF)多克隆抗體 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Hu01 嗜酸粒細胞趨化因子(ECF)多克隆抗體 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
